Seattle Vaccine and Prevention CRS
Seattle, Washington, United States
Research institute in Seattle, Washington
901 Boren Ave Suite 1320, Seattle, WA 98104
About Seattle Vaccine and Prevention CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
23
HIV Vaccine Trials Network
2
Janssen Vaccines & Prevention B.V.
2
COVID-19 Prevention Network
1
Clinical Trials at Seattle Vaccine and Prevention CRS
During the past decade, Seattle Vaccine and Prevention CRS conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults
2006-11-01
2012-12-01
Completed
90
Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
2007-08-01
2013-01-01
Completed
17
Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
2007-07-01
2012-11-01
Completed
35
Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector
2009-02-01
2015-04-01
Completed
192
Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
2009-01-01
2014-09-01
Completed
299
Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men
2009-05-01
2017-10-06
Terminated
2,504
Early Immune Responses to Vaccination - A Substudy to HVTN 205
2009-07-01
2012-07-01
Completed
47
Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
2011-05-01
2017-11-22
Completed
17
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Vaccine and Prevention CRS"
#1 collaborator was "HIV Vaccine Trials Network" with 7 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "CHAVI" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Dynavax Technologies Corporation" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Seattle Vaccine and Prevention CRS
According to Clinical.Site data, the most researched conditions in "Seattle Vaccine and Prevention CRS" are
"HIV Infections" (23 trials), "COVID-19" (2 trials), "Healthy" (2 trials), "SARS-CoV-2" (2 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "Seattle Vaccine and Prevention CRS" in a lesser frequency.
Clinical Trials Intervention Types at Seattle Vaccine and Prevention CRS
Most popular intervention types in "Seattle Vaccine and Prevention CRS" are "Biological" (25 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Ad26.Mos4.HIV" (2 trials), "DNA-HIV-PT123 vaccine" (2 trials), "MVA/HIV62 vaccine" (2 trials) and "Sample collection" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Seattle Vaccine and Prevention CRS
The vast majority of trials in "Seattle Vaccine and Prevention CRS" are
26 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Seattle Vaccine and Prevention CRS
Currently, there are NaN active trials in "Seattle Vaccine and Prevention CRS".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 23 completed trials in Seattle Vaccine and Prevention CRS,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Seattle Vaccine and Prevention CRS, 20 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".